SPOTLIGHT: FDA hold lifted on Cortex drug

The FDA has lifted a clinical hold put on a study of Cortex's Ampakine CX717 for Alzheimer's. Cortex agreed to the FDA's dose range and has been gathering new toxicology data. Cortex stock jumped 18 percent on the news. Report